Alaa A Shafie*

Consultant and Associate Professor of Medical Genetics, College of Applied Medical Sciences, Taif University, Taif, Kingdom of Saudi Arabia

*Corresponding Author: Alaa A Shafie, Consultant and Associate Professor of Medical Genetics, College of Applied Medical Sciences, Taif University, Taif, Kingdom of Saudi Arabia.

Received: July 21, 2023; Published: October 28, 2023

Abstract

The mind-numbing cases of COVID-19 and repetitive waves of its infection worldwide with massive progression of genetic mutations and virulence abilities had dire consequences on human health, scarcity of healthcare facilities, job crisis, diminished supplies of food and essentials and high rate of morbidity and mortality among young population. This time the storm may not take lives but also livelihoods. Successive shutting barriers between the nations may not just be the answer to tackling the maniac virus. Quality of life and livelihood in many nations have been severely impacted after lockdowns, more so in developing countries. Many areas across the world face acute and chronic food scarcity. Due to the increased lethality of omicron variants of SARS-CoV-2 and growing concern over its devastating effects, it is necessary to identify the potential consequences and develop a powerful strategy to combat the upcoming challenges. Here, I addressed the pandemic challenges, pathogenicity, social-health inequalities, bitter consequences and possible solutions to fight future pandemic bursts.

Keywords: Pandemic; Omicron; SARS-Cov2; Covid-19 Epidemic; Challenges; Inequalities

References

1. Ledford H. “How severe are Omicron infections?” Nature 600 (2021): 577-578.
2. Damavandi PT. “The Omicron variant and potential predictions of secondary Infections”. OSF Preprints (2021).
3. Harvey WT., et al. “SARS-CoV-2 variants, spike mutations and immune escape”. Nature Reviews Microbiology 19 (2021): 409-424.
4. Greaney AJ., et al. “Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition”. Cell Host and Microbe 29 (2021): 44-57. e49.
5. Gong SY., et al. “Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity”. Virology 563 (2021): 134-145.
6. Papanikolaou V., et al. “From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants”. Gene 814 (2022):146134-146134.
7. Zahradník J., et al. “SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution”. Nature Microbiology 6 (2021): 1188-1198.
8. Benvenuto D., et al. “Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy”. Journal of Infection 81 (2020): e24-e27.
9. Peacock TP., et al. “The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein”. bioRxiv (2012): 474653.
10. Anjum F., et al. “Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance”. Molecular and Cellular Biochemistry (2022).
11. Asrani P., et al. “Diagnostic approaches in COVID-19: clinical updates”. Expert Review of Respiratory Medicine 15 (2021): 197-212.
12. Asrani P and Hassan MI. “SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions”. Molecular and Cellular Biochemistry 476 (2021): 675-687.
13. Mishra MK. “The World after COVID-19 and its impact on Global Economy (2020).
14. Minton K. “Neutralization susceptibility of Omicron lineages”. Nature Reviews Immunology 22 (2022): 463-463.
15. Suryawanshi RK., et al. “Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination”. Nature 607 (2022): 351-355.
16. Altarawneh HN., et al. “Protection of SARS-CoV-2 natural infection against reinfection with the Omicron BA.4 or BA.5 subvariants”. medRxiv (2022): 22277448.
17. Bernstein AS., et al. “The costs and benefits of primary prevention of zoonotic pandemics”. Science Advance 8 (2022): eabl4183.
18. Marani M., et al. “Intensity and frequency of extreme novel epidemics”. Proceedings of the National Academy of Sciences of the United States of America (2021): 118.
19. Dobson AP., et al. “Ecology and economics for pandemic prevention”. Science 369 (2020): 379-381.
20. Loh EH., et al. “Targeting Transmission Pathways for Emerging Zoonotic Disease Surveillance and Control”. Vector Borne Zoonotic Dis 15 (2015): 432-437.
21. Carlson CJ., et al. “Climate change increases cross-species viral transmission risk”. Nature 607 (2022): 555-562.
22. Gibb R., et al. “Zoonotic host diversity increases in human-dominated ecosystems”. Nature 584 (2020): 398-402.
23. Cleaveland S., et al. “Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence”. Philosophical Transactions of the Royal Society B: Biological Sciences 356 (2001): 991-999.
24. Weigang S., et al. “Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants”. Nature Communications 12 (2021): 6405.
25. Bambra C., et al. “The COVID-19 pandemic and health inequalities”. Journal of Epidemiology and Community Health 74 (2020): 964-968.
26. Mamelund S-E and Dimka J. “Social inequalities in infectious diseases”. Scandinavian Journal of Public Health 49 (2021): 675-680.
27. Gu T., et al. “Characteristics Associated with Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System”. JAMA New Open 3 (2020): e2025197.
28. Clouston SAP and Link BG. “A Retrospective on Fundamental Cause Theory: State of the Literature and Goals for the Future”. Annual Review of Sociology 47 (2021): 131-156.
29. Bollyky TJ., et al. “Epidemiology, not geopolitics, should guide COVID-19 vaccine donations”. Lancet 398 (2021): 97-99.
30. Zapata-Moya ÁR., et al. “The (re)production of health inequalities through the process of disseminating preventive innovations: the dynamic influence of socioeconomic status”. Health Sociology Review 28 (2019): 177-193.

Citation

Citation: Alaa A Shafie. “Omicron Genomics: New Pandemic Phase, are we Better Prepared?".Acta Scientific Nutritional Health 7.11 (2023): 44-48.

Copyright

Copyright: © 2023 Alaa A Shafie. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.